Hennion & Walsh Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,185
| Closed | -$283K | – | 776 |
|
|
2022
Q4 | $283K | Buy |
+4,185
| New | +$283K | 0.02% | 647 |
|
|
2022
Q3 | – | Sell |
-3,863
| Closed | -$255K | – | 767 |
|
|
2022
Q2 | $255K | Sell |
3,863
-681
| -15% | -$45K | 0.02% | 668 |
|
|
2022
Q1 | $301K | Buy |
4,544
+294
| +7% | +$19.5K | 0.02% | 655 |
|
|
2021
Q4 | $247K | Sell |
4,250
-1,150
| -21% | -$66.8K | 0.01% | 677 |
|
|
2021
Q3 | $324K | Sell |
5,400
-13,616
| -72% | -$817K | 0.02% | 618 |
|
|
2021
Q2 | $1.14M | Sell |
19,016
-964
| -5% | -$57.7K | 0.06% | 335 |
|
|
2021
Q1 | $993K | Buy |
+19,980
| New | +$993K | 0.06% | 356 |
|